Jake Weeks
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 9
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 5
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects 9
-
- Adipose Tissue and Metabolism 3
- Nitric Oxide and Endothelin Effects 2
-
- Liver Disease Diagnosis and Treatment 4
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- Veterinary Pharmacology and Anesthesia 2
-
- Estrogen and related hormone effects 2
- Co-authors
- John A. JonesDonald W. DuCharmeZalman AmitZavie W. BrownJohn R. SchultzWendy BrownWilliam L. MillerBarney J. Magerlein
- Journals
- Prostaglandins (3 papers)Journal of Pharmacy and Pharmacology (2 papers)Journal of Pharmaceutical Sciences (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Jake Weeks
25 papers receiving 624 citations
Peers
Comparison fields: 5 of 97
- Pharmacology 250
- Biochemistry 99
- Cellular and Molecular Neuroscience 142
- Pharmacology 53
- Physiology 151
Countries citing papers authored by Jake Weeks
This map shows the geographic impact of Jake Weeks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jake Weeks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jake Weeks more than expected).
Fields of papers citing papers by Jake Weeks
This network shows the impact of papers produced by Jake Weeks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jake Weeks. The network helps show where Jake Weeks may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jake Weeks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 12 | |
| 6 | 1980 | 18 | |
| 7 | 1979 | 3 | |
| 8 | 1979 | 10 | |
| 9 | The general pharmacology of prostacyclin PGI2, (PGX): a new prostaglandin especially active on the cardivascular system. | 1978 | 1 |
| 10 | The general pharmacology of prostacyclin (pgi2, pgx): a new prostaglandin especially activity on the cardiovascular system. | 1978 | 8 |
| 11 | 1976 | 92 | |
| 12 | 1973 | 49 | |
| 13 | 1972 | 93 | |
| 14 | 1969 | 47 | |
| 15 | Pharmacological profile of a new prostaglandin 8 iso prostaglandin e 1 | 1968 | 4 |
| 16 | 1968 | 21 | |
| 17 | 1968 | 2 | |
| 18 | Studies on the mechanism of the hypertensive effect of prostaglandin F2-alpha. | 1968 | 94 |
| 19 | 1968 | 41 | |
| 20 | 1963 | 2 |
About Jake Weeks
Jake Weeks is a scholar working on Biochemistry, Pharmacology, Small Animals, Hepatology and Physiology, having authored 28 papers that have together received 739 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (9 papers), Eicosanoids and Hypertension Pharmacology (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Adipose Tissue and Metabolism (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Veterinary Pharmacology and Anesthesia (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Pharmacology (250 citations), Biochemistry (99 citations), Cellular and Molecular Neuroscience (142 citations), Pharmacology (53 citations) and Physiology (151 citations). Jake Weeks has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include John A. Jones, Donald W. DuCharme, Zalman Amit, Zavie W. Brown, John R. Schultz, Wendy Brown, William L. Miller, Barney J. Magerlein, A Robert and F.F. Sun. Their work appears in journals such as Prostaglandins, Journal of Pharmacy and Pharmacology, Journal of Pharmaceutical Sciences, Pharmacology Biochemistry and Behavior and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.